An experimental Eli Lilly drug slowed cognitive and functional decline for people with early-stage Alzheimer’s disease in a new study that could support regulatory approval and commercial sale
that was among the first to significantly slow the worsening of the memory-robbing disease, after years of failed attempts by the drug industry to find such drugs.
In the study of more than 1,730 patients, the drug slowed patients’ decline by 35% compared with people who received a placebo over 18 months of treatment, Lilly said. “These are levels of efficacy that just haven’t been seen before in Alzheimer’s, setting a new benchmark for what’s possible in this disease,” Dr. Skovronsky said.
About 1.6% of the abnormalities were classified as serious, including two people who died from them and a third person who died after an abnormality, Lilly said.from a smaller, midstage study in 2021. Based on that study, Lilly applied for approval from the FDA. The agency said it needed more data before it could make a decision.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Eli Lilly's diabetes drug could revolutionize the US weight loss marketEli Lilly’s diabetes drug delivers promising results in a recent clinical trial. The company hopes it will be added to the U.S. weight loss market soon.
Weiterlesen »
The Book Of Eli Ending & Meaning ExplainedThe post-apocalyptic action movie The Book of Eli features a surprise twist ending that leaves audiences with a lot of unanswered questions.
Weiterlesen »
Man admits he robbed financial services company of more than $1MEli Schamovic, 41, of Lakewood, pleaded guilty to money laundering in U.S. District Court.
Weiterlesen »
Your nonacademic career is not a consolation prize“You didn’t lose the gameshow. You just found a different way to win.” ScienceCareers
Weiterlesen »
Inside the Secretive Life-Extension ClinicLongevity evangelists are injecting people with experimental gene therapies. There are no guarantees—and no refunds.
Weiterlesen »